Literature DB >> 3526156

Empirical antimicrobial therapy in the neutropenic host.

L S Young.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3526156     DOI: 10.1056/NEJM198608283150910

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Aminoglycoside therapy: current and prospective uses.

Authors:  J E Leggett
Journal:  Tex Heart Inst J       Date:  1990

2.  Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.

Authors:  J Feliu; A Artal; M González Barón; A Berrocal; I Chacón; M L García de Paredes; E Espinosa; A Ordóñez; P Zamora; J M Montero
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

Review 3.  Antimicrobial agent therapy for Pseudomonas aeruginosa.

Authors:  J A Korvick; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

4.  Transplant infections--controversies about cost related issues.

Authors:  L S Young; M A Bermudez
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

5.  Cost analysis of 2 empiric antibacterial regimens containing glycopeptides for the treatment of febrile neutropenia in patients with acute leukaemia.

Authors:  G Bucaneve; F Menichetti; A Del Favero
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

6.  Ceftriaxone versus aztreonam plus cefazolin for infections in cancer patients with adequate neutrophil counts.

Authors:  F Menichetti; A Del Favero; G Bucaneve; V Minotti; L Patoia; S Pauluzzi
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

7.  Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides.

Authors:  J M Gatell; F Ferran; V Araujo; M Bonet; E Soriano; J Traserra; J G SanMiguel
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

8.  Empiric treatment of serious infections in patients with cancer: randomised comparison of two combinations.

Authors:  A G Maiche; L Teerenhovi
Journal:  Infection       Date:  1991       Impact factor: 3.553

9.  Evaluation of an immunofluorescent-antibody test for rapid identification of Pseudomonas aeruginosa in blood cultures.

Authors:  G W Counts; R W Schwartz; B K Ulness; D J Hamilton; M J Rosok; M D Cunningham; M R Tam; R P Darveau
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

10.  Nosocomial epiglottitis associated with penicillin- and cephalosporin-resistant Streptococcus pneumoniae bacteremia.

Authors:  R S Daum; J P Nachman; C D Leitch; F C Tenover
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.